Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure

JAMA Intern Med. 2013 Sep 9;173(16):1547-9. doi: 10.1001/jamainternmed.2013.7717.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adrenergic beta-Antagonists* / therapeutic use
  • Adult
  • Aged
  • Cardiotonic Agents / therapeutic use
  • Cohort Studies
  • Contraindications
  • Drug Utilization / statistics & numerical data*
  • Heart Failure / drug therapy*
  • Hospitalization*
  • Humans
  • Infusions, Intravenous
  • Intensive Care Units
  • Myocardial Infarction / drug therapy
  • Retrospective Studies
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • United States

Substances

  • Adrenergic beta-Antagonists
  • Cardiotonic Agents
  • Sodium Potassium Chloride Symporter Inhibitors